Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (3 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
1 selected
)
Type
Guidance (35)
Guidance programme
(
1 selected
)
Guidance programme
Cancer service guidelines (1)
Clinical guidelines (3)
Diagnostics guidance (2)
Interventional procedures guidance (5)
Medical technologies guidance (1)
NICE guidelines (4)
Technology appraisal guidance (35)
Apply filters
Showing 31 to 35 of 35
Sort by
Date
Title
Apply sorting
breast cancer
Remove breast cancer filter
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone-receptor-positive
breast cancer
that overexpresses HER2
TA257
27 June 2012
27 June 2012
Fulvestrant for the treatment of locally advanced or metastatic
breast cancer
TA239
14 December 2011
14 December 2011
Bevacizumab in combination with a taxane for the first-line treatment of metastatic
breast cancer
TA214
23 February 2011
23 February 2011
Gemcitabine for the treatment of metastatic
breast cancer
TA116
24 January 2007
24 January 2007
Guidance on the use of trastuzumab for the treatment of advanced
breast cancer
TA34
15 March 2002
15 March 2002
Previous page
1
2
3
Current page
4
Page
4
of
4
Results per page
10
25
50
All
Back to top